Connecticut · Nonprofit
ALLIANCE FOR CANCER GENE THERAPY INC
ALLIANCE FOR CANCER GENE THERAPY INC (Connecticut) receives grants from 45 organizations whose IRS filings report $5,501,877 to it, the largest being Swim Across America Inc ($3,555,000). 26 of them have funded it in more than one year.
- Revenue FY2026
- $5.2M
- Funders on record
- 45
- Grants received
- $5.5M
- Net assets
- $17M
What Alliance for Cancer Gene Therapy Inc does
Mission
Acgt supports high-risk, high-reward scientific research to develop cancer therapeutics that use the body's own cells and genes as a living medicine. By accelerating this research, acgt is helping to advance therapies that are significantly more effective and less toxic than current cancer treatments such as chemotherapy and radiation.
As stated on its FY2026 Form 990.
Program
In fiscal 4/30/26, acgt funded clinical investigator grants awarded to innovative scientists conducting translational research at premier academic institutions in the u.s., each focusing on the development of cancer cell and gene therapies for different cancers, including pancreatic, pediatric, and brain cancers, and cancer metastasis. Acgt continued multi-year collaborations with multi-disciplinary 501(c)(3) organizations focused on cell and gene therapy research. Acgt further convened its annual scientific summit and also increased public awareness of cell and gene therapy research through acgt's website, social media, and impact reports.
$2,673,605 spentof which $2,036,801 as grants$316,179 earned by the program100% of program spending
The program described on its FY2026 Form 990. Program spending in total: $2,673,605.
The organization over time
Each line starts at 100 in 2021, so what you read is the shape rather than the size: 150 means half as much again as 2021, 50 means half. The number beside each label in the key is where it ended. The shaded band is where the middle 50% of its peers' revenue would sit, given their growth.
Balance sheet
Total assets and total liabilities at each year end, in dollars. The largest one-year move in total assets was 2023 to 2024, from $7.9M to $15M (+90%).
How it's funded, over time
Each bar is one year's revenue split into where it came from, and every bar is the same height — these are shares, not amounts, so a year that raised twice as much looks the same size. Hover a bar for the split.
68% of ALLIANCE FOR CANCER GENE THERAPY INC’s revenue is contributions — about as donation-reliant as the typical peer (82% for the typical peer).
Surplus & reserves
Operating surplus or deficit each year, and months of liquidity in hand. 2 of the last 6 reported years ran a deficit.
reserve
Leadership and staff
The officers, directors, trustees and key employees listed on each return. Joined and no longer listed compare each filing with the year before, matching people by surname and first initial; a year after a gap, or a roster under three people, has no comparison.
Chief executive
Kevin Honeycutt
CEO & president
Board chair
Barbara Netter
Director, honorary chairman
As listed on its FY2026 Form 990.
Who funds it, year by year
2017 → 2023: the base broadened from 14 funders to 17 funders, grant income fell $584k → $536k.
11 of 45 of your funders are donor-advised or pass-through sponsors (tagged DAF) — 22% of grant dollars received. That money is really individual donors directing a sponsor; the institutions to cultivate are the non-DAF funders.
From the IRS filings of ALLIANCE FOR CANCER GENE THERAPY INC’s funders (the co-funder graph). Top 30 of 45 funders by total. Association, not causation. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
How concentrated its funding is
ALLIANCE FOR CANCER GENE THERAPY INC leans on a few funders — its largest provides 65% of grant income and the top three 82%; half comes from just 1 funder.
the vertical line marks half of all grant income — 1 funder to its left
88% of the income these shares are computed over arrives through pass-through sponsors or from payers whose filings do not say what kind of payment it is. Concentration is still measured over all of it, because the money is real; what it does not support is a claim about how many institutions have chosen to fund ALLIANCE FOR CANCER GENE THERAPY INC.
Largest funder’s share by year: 2017 60% · 2018 68% · 2019 64% · 2020 37% · 2021 67% · 2022 59% · 2023 63% — growing more concentrated.
“Effective funders” = inverse Herfindahl index (1 / Σ shareᵢ²) — the number of equal-sized funders that would give the same concentration. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
How long its funders stay
48% of ALLIANCE FOR CANCER GENE THERAPY INC's funders are still giving 3 years after their first grant; 58% give in more than one year at all.
Share of funders still giving k years after their first recorded grant, pooled across every acquisition cohort. A funder counts as retained in a year only if it made a grant that year. Measured to FY2023, the last fiscal year that has finished arriving — a funder cannot be counted as lapsed in a year most filers have not reached.
Where its funders are
ALLIANCE FOR CANCER GENE THERAPY INC draws 95% of its grant income from funders outside Connecticut, across 11 states in all.
In-state vs out-of-state, by year
Funder states come from each funder’s own filing. $1.2M arriving through sponsors registered in 9 states is excluded from the map and the split above: a sponsor holds money on a donor’s behalf, so its registered address would place those dollars somewhere no donor need ever have been. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
Against its field
ALLIANCE FOR CANCER GENE THERAPY INC holds deeper cash reserves than three-quarters of the 35 philanthropy nonprofits its size.
this organization peer median middle 50% of peers· 35 philanthropy nonprofits $1M–$10M, FY2026
Organizations like ALLIANCE FOR CANCER GENE THERAPY INC
Organizations whose mission and program text most resemble this one, by semantic similarity over every organization in the US filings — the closest peers, and often the clearest route to shared or prospective funders.
In Connecticut
Nationally
Read directly from this organization’s own Form 990, as neutral context.
Where the money goes
85% of spending goes to programs.
Governance
Public support
49%
Share of support from the public (Schedule A) — the basis for its public-charity status.
Footprint & structure
Files a return copy in 35 states
Screen this organization
A dated, signed PDF of the compliance screen for ALLIANCE FOR CANCER GENE THERAPY INC: IRS status (Business Master File, Publication 78, auto-revocation), the OFAC sanctions lists, the Internal Revenue Bulletin, and California registration, with the Rev. Proc. 2018-32 §8.01 reliance elements stated element by element. Generated from the current files at the moment you download it.
Screens are triage, not determinations; a source that cannot be read reports not screened, never clear. Screen this nonprofit · How the screen works · on the API as GET /api/screening/{ein}?format=pdf
Questions and answers
- Who funds ALLIANCE FOR CANCER GENE THERAPY INC?
- ALLIANCE FOR CANCER GENE THERAPY INC (Connecticut) receives grants from 45 organizations whose IRS filings report $5,501,877 to it, the largest being Swim Across America Inc ($3,555,000). 26 of them have funded it in more than one year.
- How many funders does ALLIANCE FOR CANCER GENE THERAPY INC have?
- IRS filings report 45 organizations giving $5,501,877 in grants to ALLIANCE FOR CANCER GENE THERAPY INC, 26 of which have funded it in more than one year.
- Who is the largest funder of ALLIANCE FOR CANCER GENE THERAPY INC?
- Swim Across America Inc is the largest funder on record, with $3,555,000 in grants. The full list of funders is on this page.
- How can an organization like ALLIANCE FOR CANCER GENE THERAPY INC find more funders?
- Start with the funders already giving here, then look at the foundations that back similar organizations in Connecticut. The funding by cause and by state pages list the largest funders for a given area and how to approach them.
These figures are read directly from IRS Form 990 / 990-PF e-file XML: this organization’s own return for FY2026 (financials across 2021–2026), and the filings of 45 funders that report grants to it. “On record” means captured in the filings we have parsed — a funder that does not e-file, or whose grant detail is not itemized, will not appear. Filings run roughly 12–24 months behind. Trends on this page end at FY2023, the last fiscal year that has finished arriving; later years are shown and marked, and move no figure. Data on this page was exported October 22, 2026. What this page cannot tell you · view filing